EUVIMEDEUVIMED entdecken
Crossref

Lower limb amputation rates among Medicare beneficiaries with diabetic foot ulcers managed with and without native collagen matrix plus PHMB antimicrobial

Urvi Desai, J Bradford Rice, Serena Kongara, Robert S Kirsner

Journal of Wound Care · 02.08.2026 · 35 (8) · 621-628

DOI: 10.12968/jowc.2026.0291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Wound Care, erschienen am 02.08.2026. Verfasst von Urvi Desai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Analysis Group, Inc., Boston, MA, US. Hauptthemen laut MEDLINE: Diabetic Foot, Amputation, Surgical, Biguanides, Lower Extremity. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study compared rates of non-traumatic lower limb amputations (‘amputations’) among Medicare beneficiaries with diabetic foot ulcers (DFUs) who initiated purified native type 1 collagen matrix plus polyhexamethylene biguanide (PHMB) antimicrobial (PCMP) versus those beneficiaries who did not receive PCMP.

Method

In this retrospective matched cohort study, two groups of beneficiaries with DFUs were retrospectively identified from 100% Medicare Fee-for-Service Standard Analytic Files (Quarter 1 2015–Quarter 3 2023)—those receiving PCMP within six months of DFU diagnosis (index date=first PCMP claim) and those who did not receive PCMP. Beneficiaries were matched 1:1. Using Wilcoxon signed-rank tests, six-month post-index amputation rates were compared. Stratified analysis evaluated amputation rates among beneficiaries initiating PCMP within 45, 60 or 90 days of DFU diagnosis, with follow-up applications every 7–14 days for one month.

Results

Before matching, beneficiaries receiving PCMP (n=10,939) had greater disease severity, as indicated by longer duration of active ulceration and higher amputation rates in the six months pre-index date than those beneficiaries who never received PCMP (n=657,233). After matching, baseline characteristics were well balanced (n=10,862). During follow-up, beneficiaries receiving PCMP had lower six-month amputation rates than those in the matched non-PCMP cohort (9.9% versus 12.2%, respectively; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic FootAmputation, SurgicalBiguanidesLower ExtremityCollagen Type ICollagenHumansUnited StatesFemaleMaleRetrospective StudiesMedicareAgedAged, 80 and overWound Healing

Stichwörter der Autor:innen

MedicarePCMPamputationcollagen matrixdiabetesdiabetic foot ulcerspolyhexamethylene biguanidewoundwound carewound dressingwound healing

Substanzen

BiguanidespolihexanideCollagen Type ICollagen

Autor:innen und Institutionen

  • Analysis Group, Inc., Boston, MA, US.
  • Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Hospital and Clinics Wound Center, University of Miami Miller School of Medicine, Miami, FL, US.

Zitieren

APA

Desai, U., Rice, J. B., Kongara, S., & Kirsner, R. S. (2026). Lower limb amputation rates among Medicare beneficiaries with diabetic foot ulcers managed with and without native collagen matrix plus PHMB antimicrobial. Journal of Wound Care, 35(8), 621-628. https://doi.org/10.12968/jowc.2026.0291

Vancouver

Desai U, Rice JB, Kongara S, Kirsner RS. Lower limb amputation rates among Medicare beneficiaries with diabetic foot ulcers managed with and without native collagen matrix plus PHMB antimicrobial. Journal of Wound Care. 2026;35(8):621-628. doi:10.12968/jowc.2026.0291

BibTeX
@article{Desai2026,
  author = {Desai, Urvi and Rice, J Bradford and Kongara, Serena and Kirsner, Robert S},
  title = {Lower limb amputation rates among Medicare beneficiaries with diabetic foot ulcers managed with and without native collagen matrix plus PHMB antimicrobial},
  journal = {Journal of Wound Care},
  year = {2026},
  volume = {35},
  number = {8},
  pages = {621--628},
  doi = {10.12968/jowc.2026.0291}
}
Kostenlos starten →